Therapeutic kinase modulators

Details Therapeutic kinase modulators Therapeutic kinase modulators

2011-03-22

2011-03-22

Wilson, James O (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C546S088000

Reexamination Certificate

active

07910600

ABSTRACT:
The invention relates in part to molecules having certain biological activities that include, but are not limited to, inhibiting cell proliferation, and modulating protein kinase activity. Molecules of the invention can modulate casein kinase (CK) activity. The invention also relates in part to methods for using such molecules.

REFERENCES:
patent: 4110450 (1978-08-01), Barreau et al.
patent: 5624677 (1997-04-01), El-Rashidy et al.
patent: 5766863 (1998-06-01), Godowski et al.
patent: 7406392 (2008-07-01), Gedlinske et al.
patent: 2003/0065180 (2003-04-01), Tsou et al.
patent: 2003/0069265 (2003-04-01), Saxena et al.
patent: 2006/0029950 (2006-02-01), Whitten et al.
patent: 2006/0074089 (2006-04-01), Whitten et al.
patent: WO-2004/007754 (2004-01-01), None
Rewcastle, et al., Synthesis of 4-(Phenylamino)pyrimidine Derivatives as ATP-competitive Protein Kinase Inhibitors with Potential for Cancer Chemotherapy, Current Organic Chemistry, 4, 679-706 (2000).
International Search Report and Written Opinion for PCT/US08/74820, mailed Aug. 17, 2009, 10 pages.
Rewcastle et al., Current Organic Chemistry (2000) 4:679-706.
Calebrese et al., Clin Cancer Res (2003) 9:2711-2718.
Calebrese et al., J Nat'l Cancer Inst (2004) 96(1):56-67.
Curtin, Expert Reviews in Molecular Medicine (2005) 7(4):1-20.
Di Paola et al., Eur J Pharmacology (2005) 527(1-3):163-171.
Jagtap, Nature Rev: Drug Discovery (2005) 4:421-440.
GenBank Database Accession No. NM—002019, Kommineni et al. (2008).
GenBank Database Accession No. NM—002020, Tammela et al. (2008).
GenBank Database Accession No. NM—002648, Hosgood et al. (2008).
GenBank Database Accession No. NM—004119, Paschka et al. (2008).
GenBank Database Accession No. NM—006875, Morishita et al. (2008).
GenBank Database Accession No. NP—002010, Kommineni et al. (2008).
GenBank Database Accession No. NP—002011, Tammela et al. (2008).
GenBank Database Accession No. NP—002639, Hosgood et al. (2008).
GenBank Database Accession No. NP—004110, Paschka et al. (2008).
GenBank Database Accession No. NP—006866, Morishita et al. (2008).
GenBank Database Accession No. XM—938171 (2006).
GenBank Database Accession No. XP—943264 (2006).
Li et al., Pain (2005) 115(1-2):182-190.
Parhar et al., Int J Colorectal Dis (2006) 22(6):601-609.
U.S. Appl. No. 11/849,230, filed Aug. 31, 2007 [Chua et al.].
U.S. Appl. No. 60/803,864, filed Jun. 3, 2006 [Lim et al.].
U.S. Appl. No. 60/811,990, filed Jun. 8, 2006 [Pierre et al.].
U.S. Appl. No. 60/811,992, filed Jun. 8, 2006 [Nagasawa et al.].
U.S. Appl. No. 60/904,694, filed Mar. 1, 2007 [Nagasawa et al.].
Veuger et al., Cancer Res (2003) 63:6008-6015.

Affiliated with

Also associated with

Rating

Therapeutic kinase modulators does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Therapeutic kinase modulators, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic kinase modulators will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2751082